Lifestyle changes in obese patients with type 2 diabetes can decrease some complications and even medical costs, but….
Read More »Diabetes In Control
ADA: Novel Aggressive Treatment for Newly Diagnosed Type 2’s
Patients started on three therapeutic agents simultaneously.…
Read More »ADA: Newly Diagnosed Less Likely to Adhere to Diabetes Medications
Non-adherence to diabetes medication is more likely to occur among young adults, women, those who use retail pharmacies and those who are new to diabetes therapies….
Read More »ADA: Hypoglycemia Poorly Controlled
Glucose control has been improving but serious hypoglycemia and insulin mistakes resulting in emergency care are not improving….
Read More »ADA: SGLT2 Inhibitor Works in Type 1 Diabetes as Add-on to Insulin
An investigational agent for type 2 diabetes may also work as add-on therapy in type 1 disease….
Read More »ADA: Smart Phone Tracks Blood Sugar with Artificial Pancreas
The first wearable artificial pancreas platform based on a smart phone passes early feasibility tests….
Read More »ADA: Bariatric Surgery May Increase Risk for Retinopathy
A small study warns that weight-loss surgery might accelerate progression of diabetic retinopathy….
Read More »ADA: Relooking at Carb Counting in T1D
The evidence for counting carbs is not substantial….
Read More »ADA: New CVD Predictor for Type 1 Diabetes Found
Serum osteoprotegerin is an independent predictor of cardiovascular complications…
Read More »What Level of A1c Lowering Yields the Most Benefits and Least Risk?
Five years after the release of the ACCORD and ADVANCE studies, some physicians are still searching for answers….
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.